Skip to main content
. 2021 May 31;12(6):561. doi: 10.1038/s41419-021-03844-z

Fig. 3. Identification of ZEB1 as the mediator involved in the therapeutic effects conferred by STAT3 inhibition.

Fig. 3

A Protein levels of ZEB1, E-cadherin, vimentin, and N-cadherin were detected by western blot in A549, A549/GR, PC-9, and PC-9/GR cells. B STAT3 regulated the expression of ZEB1, E-cadherin, vimentin, and N-cadherin. The expression levels of the indicated proteins were examined by Western blot. C Correlation analysis between STAT3 and ZEB1 in tumor tissue. D Correlation analysis between STAT3 and ZEB1 in normal tissue. E Downregulation of ZEB1 increases the sensitivity of lung cancer cells to gefitinib. Cell viability was determined using the MTT assay. Downregulation of ZEB1 inhibits cell invasion (F) and migration (G). H ZEB1 regulated the expression of E-cadherin, vimentin, and N-cadherin. The expression levels of the indicated proteins were examined by Western blot.